Results 1 to 10 of about 27,814 (145)

Interleukins decrease epithelial protein and gene expression by K14 + CD105+ equine hoof progenitor cells [PDF]

Stem Cell Research & Therapy
Background Progenitor cell epithelial to mesenchymal transition (EMT) could impact healing in the epidermal-dermal junction of the equine hoof stratum internum (SI).
Qingqiu Yang, Mandi J. Lopez
doaj   +2 more sources

Distinctive features of cancer-associated fibroblasts expressing CD105, a novel biomarker for bone metastasis, in early-stage invasive ductal breast cancer [PDF]

Frontiers in Endocrinology
PurposeCancer-associated fibroblasts (CAFs) are highly heterogeneous and critically influence breast cancer progression, yet functionally relevant stromal subpopulations remain poorly defined.
María Belén Giorello, Francisco Raúl Borzone, Francisco Raúl Borzone, María Cecilia Sanmartin, Leandro Marcelo Martinez, Mrinmoy Sarkar, Tapasree Roy Sarkar, Vivian Labovsky, Alejandra Wernicke, Norma Alejandra Chasseing   +9 more
doaj   +2 more sources

SSEA3 and CD105 positivity are associated with the treatment potency of human neural crest-derived nasal turbinate stem cells for Alzheimer’s disease [PDF]

Translational Neurodegeneration
Background Stem cells have the potential to treat Alzheimer’s disease (AD), but clinical outcomes are unpredictable due to inter-donor differences in stem cell properties.
Jung Yeon Lim, Jung Eun Lee, Minho Lee, Haewon Shim, Sang In Park, Soon A. Park, Sin-Soo Jeun, Sheng-Min Wang, Sunghwan Kim, Seung Ho Yang, Hyun Kook Lim, Sung Won Kim   +11 more
doaj   +2 more sources

Profiles of Endoglin and Vascular Endothelial Growth Factor Based on Staging and Histological Grading of Colorectal Cancer and Their Relationship with Bevacizumab Therapy

Journal of Coloproctology, 2021
Objective The present study evaluated the profile of endoglin (CD105) and vascular endothelial growth factor (VEGF) based on staging and histopathological grading of colorectal cancer as well as their relationship with bevacizumab therapy ...
Rahmawati Minhajat, Sahyuddin Saleh, Tutik Harjianti, Andi Fachruddin Benyamin, A. M. Luthfi Parewangi, Syakib Bakri   +5 more
doaj   +1 more source

Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology

OncoImmunology, 2022
The modeling of chimeric antigen receptor (CAR) T cell therapies has been mostly focused on immunodeficient models. However, there are many advantages in studying CAR-T cell biology in an immunocompetent setting. We generated a fully murine CAR targeting
Konstantinos Lontos, Yiyang Wang, Mason Colbert, Alok Kumar, Supriya Joshi, Mary Philbin, Yupeng Wang, Andrew Frisch, Jason Lohmueller, Dayana B. Rivadeneira, Greg M. Delgoffe   +10 more
doaj   +1 more source

Measurement of Microvessel Density Using CD105 (Endoglin) as a Marker in Prostatic Adenocarcinoma

Annals of Urologic Oncology, 2023
Introduction Angiogenesis has been proposed as a promising prognostic marker in a variety of tumours. Microvessel density (MVD) measurement is the most reliable method for the semiquantitative evaluation of angiogenesis.
Sheenam Azad, Garima Sharma, Monika Kochhar, Saqib Ahmed, Seema Acharya, Sadaf Khan   +5 more
doaj   +1 more source

CD105 and CD34 as Markers of Angiogenesis of Urothelial Carcinoma: A Cross Sectional Study

Annals of Urologic Oncology, 2023
Background Urothelial carcinoma (UC) of the bladder is a major cause of morbidity and mortality throughout the world. The present study was carried out to see the expression of CD105 and CD34 as marker of angiogenesis in UC and study their relationship ...
Sheenam Azad, Aditi Bisht, Avneesh Malviya, Jyotsna Bhateja, Seema Acharya   +4 more
doaj   +1 more source

CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities. [PDF]

PLoS ONE, 2013
Administration of in vitro expanded mesenchymal stromal cells (MSCs) represents a promising therapy for regenerative medicine and autoimmunity. Both mouse and human MSCs ameliorate autoimmune disease in syn-, allo- and xenogeneic settings.
Per Anderson, Ana Belén Carrillo-Gálvez, Angélica García-Pérez, Marién Cobo, Francisco Martín   +4 more
doaj   +1 more source

Morphological peculiarities of revascularization of perifocal areas of brain infarction

Patologìâ, 2023
Aim. To study pathomorphological signs of revascularization of perifocal areas of brain infarction in the dynamics of the acute period of the disease. Material and methods. Perifocal areas of brain infarction in patients who died at the 1st, 3rd, 7th,
S. I. Tertyshnyi, О. О. Voloshanska, А. М. Serheieva   +2 more
doaj   +1 more source

Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy

Signal Transduction and Targeted Therapy, 2021
Chimeric antigen receptor-based T-cell immunotherapy is a promising strategy for treatment of hematological malignant tumors; however, its efficacy towards solid cancer remains challenging.
Fengzhen Mo, Siliang Duan, Xiaobing Jiang, Xiaomei Yang, Xiaoqiong Hou, Wei Shi, Cueva Jumbo Juan Carlos, Aiqun Liu, Shihua Yin, Wu Wang, Hua Yao, Zihang Yu, Zhuoran Tang, Shenxia Xie, Ziqiang Ding, Xinyue Zhao, Bruce D. Hammock, Xiaoling Lu   +17 more
doaj   +1 more source